Conflict of interest: Dr. Cohen has received research grants from Boston Scientific, Abbott Vascular, Eli Lilly, Daiichi-Sankyo, Merck-Schering Plough as well as consulting fees from Cordis and Medtronic. Dr. Van Hout has received grant support from Boston Scientific. Dr. Pinto is on the speaker's bureau of Eli Lilly, and Daiichi-Sankyo and has received research grants from Medicines Company and Genentech as well as consulting fees from the Medicines Company, Rox Medical and Medtronic. Dr. Mahoney has received grant support from Sanofi-Aventis, Bristol-Myers Squibb, Eli Lilly, and Daiichi-Sankyo, and has received honoraria from Sanofi-Aventis and Bristol-Myers Squibb. Dr. Mcgarry is on the speaker's bureau of Boston Scientific. Dr. Horwitz has received grant support from Boston Scientific. Drs. Serruys and Mohr were the SYNTAX study Principal Investigators and Dr. Kappetein was a Co-Principal Investigator. All other authors have no disclosures.
Coronary Artery Disease
Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: One-year results from the SYNTAX trial†
Article first published online: 26 SEP 2011
Copyright © 2011 Wiley Periodicals, Inc.
Catheterization and Cardiovascular Interventions
Volume 79, Issue 2, pages 198–209, 1 February 2012
How to Cite
Cohen, D. J., Lavelle, T. A., Van Hout, B., Li, H., Lei, Y., Robertus, K., Pinto, D., Magnuson, E. A., Mcgarry, T. F., Lucas, S. K., Horwitz, P. A., Henry, C. A., Serruys, P. W., Mohr, F. W. and Kappetein, A. P. (2012), Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: One-year results from the SYNTAX trial. Cathet. Cardiovasc. Intervent., 79: 198–209. doi: 10.1002/ccd.23147
- Issue published online: 23 JAN 2012
- Article first published online: 26 SEP 2011
- Accepted manuscript online: 3 MAY 2011 02:16PM EST
- Manuscript Accepted: 19 MAR 2011
- Manuscript Received: 16 FEB 2011
- Boston Scientific Corporation, Natick, MA
Additional Supporting Information may be found in the online version of this article.
|CCD_23147_sm_SuppTab1.doc||53K||Supporting Table I.|
|CCD_23147_sm_SuppTab2.doc||38K||Supporting Table II.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.